Royalty Report: Coating, Medical, Drugs – Collection: 27977

$100.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 4

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4

Primary Industries

  • Coating
  • Medical
  • Drugs
  • Chemicals
  • Supply
  • Delivery
  • Biotechnology
  • Coating surface
  • Pharmaceuticals
  • Device

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 27977

License Grant
The Canadian University grants to the Licensee an exclusive worldwide license to use and sublicense the Technology and any Improvements within the Field of Use and to manufacture, distribute and sell the Products within the Field of Use on the terms and conditions set out in this Agreement.
License Property
US Patent Application No.  09/838,331 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation.

University will provide the Hydroxyapatite coatings which are to be applied on stents to be provided by the Licensee.

Field of Use
'FIELD OF USE' means the Technology and any Improvements will be used to produce hydroxyapatite and related calcium phosphate compounds on medical devices and on scaffolding, wherein 'scaffolding' means stents, gauze, wires, wire mesh, films or microscale particles. For greater certainty, the Field of Use shall not include any use of the Technology or Improvements to produce hydroxyapatite and related calcium phosphate compounds on or for orthopaedic implantables, trauma fixation devices, dental implants and bone substitutes.

IPSCIO Record ID: 26775

License Grant
The Canadian University grants to the Licensee an exclusive worldwide license to use and sublicense the Technology and any Improvements within the Field of Use and to manufacture, distribute and sell the Products within the Field of Use on the terms and conditions set out in this Agreement.
License Property
License to use intellectual property relative to Thin HA Coating.  Exploitations will include technology and any improvements used to produce hydroxyapatite and related calcium phosphate compounds on medical devices and on scaffolding, wherein 'scaffolding' means stents, gauze, wires, wire mesh, films or microscale particles.  Both parties to transaction are located in Bristish Columbia, Canada.

US Patent No. 6,426,114 Sol-gel calcium phosphate ceramic coatings and method of making same filed May 2, 2000.

Field of Use
'FIELD OF USE' means the Technology and any Improvements will be used to produce hydroxyapatite and related calcium phosphate compounds on medical devices and on scaffolding, wherein 'scaffolding' means stents, gauze, wires, wire mesh, films or microscale particles.

IPSCIO Record ID: 27324

License Grant
The Company and the University entered into a license agreement granting the Company an exclusive, worldwide right and license to use and sell products that utilize technology protected by the University of Pennsylvania’s patent rights for use in medical, dental and veterinary fields for growth of bone cells, fixing human prosthetic devices, coating human prosthetic devices, including bone growth onto or into modified human prosthetic device and/or producing human prosthetic devices.
License Property
The University owns and is a proprietor of certain intellectual property developed relating to novel materials and techniques for improving orthopedic implants.
Field of Use
Field of Use means the use of Penn Technical Information and/or Penn Patent Rights  for use in medical, dental and veterinary fields for growth of bone cells, fixing human prosthetic devices, coating human prosthetic devices, inducing bone growth onto or into modified human prosthetic devices, and/or producing human prosthetic devices.

IPSCIO Record ID: 5753

License Grant
Licensor hereby grants to Implant a perpetual, worldwide, royalty free license to use any and all technology specifically developed by Licensor for use in the manufacture or coating of the Stents. Licensor hereby agrees to execute and deliver any and all additional documentation Implant reasonably deems necessary or desirable to transfer to Implant the rights set forth in this agreement.
License Property
The parties hereto desire to develop polymer covered or coated vascular stents utilizing proprietary technologies of each party.

The parties agree that upon completion of the research and development contemplated by this Agreement, they will negotiate and enter into an agreement pursuant to which the Licensee will have the exclusive right to manufacture and sell the Stents.

Field of Use
The rights granted relate to vascular stents.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.